Completed NCT01500694
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Graz Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 6 Years to 17 Years
Countries France, United Kingdom, Belgium, ...
Sponsor Shire
Condition ADHD Completed NCT01692782
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Encino Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition ADHD Withdrawn NCT07169162
This summary needs review. Please check the official study record and contact the research team for details.
In Las Vegas Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 5 Years
Countries United States
Sponsor Aytu BioPharma, Inc.
Condition ADHD Completed NCT00269776
This study is completed. It focuses on ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries
Sponsor Alza Corporation, DE, USA
Condition ADHD Completed NCT00304681
This study is completed. It is testing CONCERTA* vs.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries
Sponsor Janssen-Ortho Inc., Canada
Condition ADHD Completed NCT00192023
This study is completed in Italy. It is testing efficacy of Atomoxetine for ADHD.
Multiple locations, including Alessandria Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 15 Years
Countries Italy
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00337285
This study is completed in the United States. It is testing NRP104 for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor New River Pharmaceuticals
Condition ADHD Completed NCT00636818
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Beijing Why is this study shown? This study is directly about ADHD.
ADHD Drug Over 18 Years
Countries China, South Korea, Taiwan
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00485459
This summary needs review. Please check the official study record and contact the research team for details.
In Taipei Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 16 Years
Countries Taiwan
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00530335
This study is completed in Japan. It focuses on ADHD.
Multiple locations, including Aichi Why is this study shown? This study is directly about ADHD.
ADHD Drug Over 18 Years
Countries Japan
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00962104
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Aichi Why is this study shown? This study is directly about ADHD.
ADHD Drug Over 18 Years
Countries Japan, South Korea, Taiwan
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00568685
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Bucheon-si Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 6 Years to 18 Years
Countries South Korea
Sponsor Eli Lilly and Company
Condition ADHD Data coverage Public registry coverage is progressing HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.